ResearcherCentre Hospitalier Universitaire de ReimsNo recent work listed

Antoine Le Bozec

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0789-5180; OpenAlex author ID A5072649100. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC). Co-author DOI 10.3389/fphar.2023.1137791 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Florian Slimano · 1 shared paper, 2023 · strength 0.18
- Paper Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective… DOI 10.3389/fphar.2023.1137791 ↗
Mathias Brügel · 1 shared paper, 2023 · strength 0.18
- Paper Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective… DOI 10.3389/fphar.2023.1137791 ↗
Marine Perrier · 1 shared paper, 2023 · strength 0.18
- Paper Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective… DOI 10.3389/fphar.2023.1137791 ↗
Olivier Bouché · 1 shared paper, 2023 · strength 0.18
- Paper Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective… DOI 10.3389/fphar.2023.1137791 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.